Alterations in KRAS, CDKN2A, TP53, and SMAD4 Predict Disease-Free Survival in Resected Pancreatic Ductal Adenocarcinoma Morales-Oyarvide, V., Qian, Z., Rubinson, D. A., Nowak, J. A., Dunne, R. F., Kozak, M., Welch, M., Brais, L. K., Da Silva, A., Li, T., Li, W., Masuda, A., Yang, J., Shi, Y., Gu, M., Masugi, Y., Bui, J., Zellers, C., Yuan, C., Babic, A., Khalaf, N., Aguirre, A., Ng, K., Miksad, R., Bullock, A., Chang, D., Tseng, J., Clancy, T., Linehan, D., Findeis-Hosey, J., Doyle, L., Thorner, A., Ducar, M., Wollison, B., Laing, A., Hahn, W., Meyerson, M., Fuchs, C. S., Ogino, S., Hornick, J., Hezel, A., Koong, A., Wolpin, B. M. LIPPINCOTT WILLIAMS & WILKINS. 2017: 1420–21

View details for Web of Science ID 000414520800170